news details |
|
|
| Fresh notices on favouring tenders during Covid | | | Agencies
NEW DELHI, Apr 18: After Dr RN Dass, the Delhi Government's Vigilance Department has issued notices to Central Procurement Agency's (CPA) Head of Office (HOO) Dr Nitin Kumar and (SO) Urmila and Department of Consumers' (DCA) District Health Society (DHS) SK Verma regarding 'the management of the tenders in favour of a particular family in different company names'.
In a show-cause notice issued on Monday by the Vigilance Department, it said, Nitin Kumar, Urmila, and SK Verma were in the forefront in managing the tenders in favour of a particular family in different company names, and the conspiracy was hatched in the backdrop of COVID crisis. The COVID crisis was used as a reason and basis to swindle crores of Rupees from public exchequer, the notice alleged.
"Out of the 24 participants only 3 were technically qualified by the committees headed by R.N. Das (who was OSD to the then Health Minister Satyender Jain and Presently OSD to Health Minister Saurabh Bhardwaj). Qualified participants were, Pharma Surge Impex, Pharmatek India, and Tirupati Medilines Pvt Ltd, and the committee rejected bids of remaining 21 companies," the show cause notice stated.
The vigilance department has sought a response from all of them within seven days and it said the conspiracy was hatched in the backdrop of Covid crisis. The pandemic was used as a reason and basis to swindle crores of rupees from public exchequer and all the procurements were done completely ignoring the procedure to be followed by the mandate issued by Indian Council of Medical Research (ICMR).
"Health department officials have used the context of Covid for enriching these private companies and intentionally allowed cartelisation among the companies," said the notice, adding that Das chaired three committees for procurement of single use gloves, sterilised gloves and N-95 masks.
This tender was awarded based upon the circular of ICMR dated August 26, 2020 as per the supply order dated June 16, 2020 and June 6, 2020 for approximately Rs 49.50 crore. The logic that was given for SD Biosensor Healthcare Pvt Ltd is that it was recognised as a valid supplier for the RAT Kit.
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
|
|
|
|
 |
|
|
|
|
STOCK UPDATE |
|
|
 |
| BSE
Sensex |
 |
| NSE
Nifty |
|
|
| |
CRICKET UPDATE |
|
|
|
|
| |
| |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
